• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·CNTMF
Share

FLUENT Corp. Stocks

$ 0.02Last Updated 16.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 8.43M

$ 0.02
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Fluent Corp. is a comprehensive cannabis enterprise, managing all stages of its business from cultivation to retail, with licenses and active operations spanning Florida, Pennsylvania, New York, and Texas. It conducts business under its proprietary "Fluent" brand, aiming to be a premier provider of high-quality cannabis products and services for the communities it engages with. This ambition is underpinned by Fluent's unwavering pursuit of operational superiority across all key areas: growing, processing, logistics, and sales. The company's principal office is situated in Tampa, Florida. Its ordinary shares are publicly traded on the CSE as "TIUM.U" and on the OTCQB under the ticker "CNTMF." For additional corporate information, interested parties can visit www.investors.getfluent.com.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.10.2026 04:34

Anthropic is seeking an additional $45 billion in funding. The deal could support its partner Nvidia's IPO

20.10.2026 01:27

A Breather After the Plunge: Nasdaq Rebounded 1.2% as Demand for AI Stocks Returned

20.10.2026 00:18

One of Intel’s last bears gives up negative rating amid stock’s plunge

19.10.2026 22:51

Neobank Plata, founded by former Tinkoff execs, achieves $1 bln in annualized revenue

19.10.2026 22:31

Morgan Stanley raises Amazon target price, sees 40% upside on cloud growth, AI agents

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026